These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2871858)

  • 41. The safety and efficacy of ipsapirone vs. lorazepam in outpatients with generalized anxiety disorder (GAD): single site findings from a multicenter trial.
    Cutler NR; Sramek JJ; Wardle TS; Hesselink JM; Roeschen JK
    Psychopharmacol Bull; 1993; 29(2):303-8. PubMed ID: 7904761
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epidemiology and psychopharmacology of anxiety in medical patients.
    Stoudemire A
    J Clin Psychiatry; 1996; 57 Suppl 7():64-72; 73-5. PubMed ID: 8690699
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Meta-analysis of the safety and tolerability of two dose regimens of buspirone in patients with persistent anxiety.
    Sramek JJ; Hong WW; Hamid S; Nape B; Cutler NR
    Depress Anxiety; 1999; 9(3):131-4. PubMed ID: 10356651
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of buspirone in two separate studies.
    Goldberg HL; Finnerty R
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):87-91. PubMed ID: 6759499
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Use of anxiolytics in children.
    Siméon JG
    Encephale; 1993; 19(2):71-4. PubMed ID: 7903927
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lactose in buspirone.
    Pao M
    J Am Acad Child Adolesc Psychiatry; 1999 Nov; 38(11):1327. PubMed ID: 10560214
    [No Abstract]   [Full Text] [Related]  

  • 47. Buspirone's advantages over benzodiazepine anxiolytics.
    Ereshefsky L
    Clin Pharm; 1984; 3(6):654-5. PubMed ID: 6150783
    [No Abstract]   [Full Text] [Related]  

  • 48. Abecarnil for the treatment of generalized anxiety disorder: a placebo-controlled comparison of two dosage ranges of abecarnil and buspirone.
    Pollack MH; Worthington JJ; Manfro GG; Otto MW; Zucker BG
    J Clin Psychiatry; 1997; 58 Suppl 11():19-23. PubMed ID: 9363044
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Buspirone, a novel nonbenzodiazepine anxiolytic.
    Kastenholz KV; Crismon ML
    Clin Pharm; 1984; 3(6):600-7. PubMed ID: 6150781
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differential effects of the anxiolytic drugs, diazepam and buspirone, on memory function.
    Lucki I; Rickels K; Giesecke MA; Geller A
    Br J Clin Pharmacol; 1987 Feb; 23(2):207-11. PubMed ID: 2881573
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Which medications should be prescribed to treat generalized anxiety disorder (GAD)?
    Reesal RT
    J Psychiatry Neurosci; 1999 Jan; 24(1):80. PubMed ID: 11499429
    [No Abstract]   [Full Text] [Related]  

  • 52. New antianxiety agents.
    Cole JO
    Psychopharmacol Bull; 1982 Oct; 18(4):45-6. PubMed ID: 6130565
    [No Abstract]   [Full Text] [Related]  

  • 53. Tofizopam in the therapy of anxious-depressive syndromes.
    Molcan J; Novotny V; Korinkova V; Konikova M
    Agressologie; 1981 Nov; 22(D):23-4. PubMed ID: 6120663
    [No Abstract]   [Full Text] [Related]  

  • 54. A double-blind, placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepam in patients with generalized anxiety disorder: a prospective multicenter trial.
    Cutler NR; Sramek JJ; Keppel Hesselink JM; Krol A; Roeschen J; Rickels K; Schweizer E
    J Clin Psychopharmacol; 1993 Dec; 13(6):429-37. PubMed ID: 7907097
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.
    Alpert JE; Franznick DA; Hollander SB; Fava M
    J Clin Psychiatry; 2004 Aug; 65(8):1069-75. PubMed ID: 15323591
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical studies of "specific" anxiolytics as therapeutic agents.
    Rickels K
    Psychopharmacol Ser; 1987; 3():88-95. PubMed ID: 2881295
    [No Abstract]   [Full Text] [Related]  

  • 57. A study of buspirone co-presented with antihistamines in 68 anxious ambulatory patients.
    Lader MH; Napoliello MJ
    J Clin Psychopharmacol; 1988 Apr; 8(2):146-8. PubMed ID: 2897380
    [No Abstract]   [Full Text] [Related]  

  • 58. BuSpar is clarified.
    Ohio Med; 1987 May; 83(5):286. PubMed ID: 2895906
    [No Abstract]   [Full Text] [Related]  

  • 59. [Alprazolam in the treatment of anxiety disorders and mixed anxiety and depressive disorders. Results of multicenter clinical trial].
    Kiejna A; Małyszczak K; Rzewuska M; Sobucka K; Florkowski A; Rajewski A; Rajewska J; Wojtanowska M; Dabkowski M; Brzeziński R; Rybakowski J; Sep-Kowalikowa B; Gałuszko P; Nowicki Z
    Psychiatr Pol; 1996; 30(6):973-92. PubMed ID: 9132771
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Contemporary management of comorbid anxiety and depression in geriatric patients.
    Doraiswamy PM
    J Clin Psychiatry; 2001; 62 Suppl 12():30-5. PubMed ID: 11430616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.